Search
Mentha arvensis top
go.drugbank.com/drugs/DB14346InvestigationalMentha arvensis top is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Apple fruit oil
go.drugbank.com/drugs/DB14355InvestigationalApple fruit oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Moringa oleifera leaf
go.drugbank.com/drugs/DB14362InvestigationalMoringa oleifera leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Capsicum annuum whole
go.drugbank.com/drugs/DB14368InvestigationalCapsicum annuum whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Branaplam
go.drugbank.com/drugs/DB14918InvestigationalBranaplam is under investigation in clinical trial NCT02268552 (An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)).
Recombinant CD40-ligand
go.drugbank.com/drugs/DB15015InvestigationalRecombinant CD40-ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma).
Eftilagimod alfa
go.drugbank.com/drugs/DB16150InvestigationalEftilagimod alfa is under investigation in clinical trial NCT02614833 (IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma).
TG-1042
go.drugbank.com/drugs/DB18435InvestigationalTG-1042 (formerly known as ASN-002) is a recombinant adenovirus carrying the cDNA coding sequence for the human interferon gamma gene.
Synonyms: Ad-IFNγTPX-4589
go.drugbank.com/drugs/DB18604InvestigationalTPX-4589 is an antibody-drug conjugate composed of a humanized monoclonal antibody targeting CLDN18.2 and linker-payload MC-VC-PAB-MMAE.
Synonyms: Antibody drug conjugate composed of a humanized monoclonal antibody targeting CLDN18.2 and linker-payload MC-VC-PAB-MMAECV-8102
go.drugbank.com/drugs/DB19184InvestigationalCV-8102 is under investigation in clinical trial NCT03203005 (IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients).